We analysed the time from diagnosis to death for people from the East of England with a new diagnosis of malignant melanoma (International Classification of Diseases 10 site code C43) during 2006 2010, with follow-up on mortality until 15 March 2012.
Newly diagnosed cancer patients defined by those who have been first-ever hospitalized with a primary diagnosis of malignant disease (International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code (ICD-9-CM codes: 140 208)) between January 1 , 2001and December 31, 2008 were identified.
Jiao, Y. et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.
The tumor, node, metastasis classification of malignant uveal melanoma has been revised.
National guidelines are increasingly based on standardised classification of malignant risk [1, 22] (as opposed to subjective assessment by experienced individuals); therefore reducing inter-observer variation is particularly relevant [1, 21, 22].
However, histological classification of malignant gliomas can be difficult, especially if only small amounts of stereotactic biopsies are available [6].
The tumors were classified according to TNM stage (tumor, node, metastasis) based on the UICC criteria (Sobin LH, Wittekind C, 1997, TNM classification of malignant tumors. New York.
The information documented included clinical TNM staging (tumor, node, and metastasis based on the Union International Center le Cancer TNM classification of malignant tumors 2002), site of the lesion, histopathological differentiation, age, gender, and tobacco consumption habits.
The information documented included clinical TNM staging (tumor, node, metastasis based on the Union International Center le Cancer TNM classification of malignant tumors 2002), site of the lesion, histopathological grade (WD, MD, PD), age, gender, and tobacco consumption habits.
Patients with metastatic disease at (stage 4 of TNM Classification of Malignant Tumors [1]) diagnosis have a relatively poor prognosis (5-year overall survival of 50% or lower) with current therapy such as multiagent standard-dose chemotherapy followed by surgical operation [6].
§ Sobin LH, Wittekind C. TNM classification of malignant tumours.
